ProQR Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.About PRQR
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.
PRQR Key Statistics
Stock Snapshot
As of today, ProQR Therapeutics(PRQR) shares are valued at $1.61. The company's market cap stands at 167.52M, with a P/E ratio of -3.16.
During the trading session on 2026-05-17, ProQR Therapeutics(PRQR) shares reached a daily high of $1.65 and a low of $1.57. At a current price of $1.61, the stock is +2.5% higher than the low and still -2.4% under the high.
Trading volume for ProQR Therapeutics(PRQR) stock has reached 413.82K, versus its average volume of 501.97K.
The stock's 52-week range extends from a low of $1.33 to a high of $3.10.
The stock's 52-week range extends from a low of $1.33 to a high of $3.10.
PRQR News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.